Sunday, November 26 | 3:10 p.m.-3:20 p.m. | S4-SSCH02-1 | Room N228
A study on how intervention strategies for women undergoing screening mammography can also improve lung cancer screening enrollment will be highlighted in this scientific presentation.
Kim Lori Sandler, MD, in her talk will showcase findings from her team that showed targeted outreach to patients and providers in the Coordinate A Lung screening with Mammography (CALM) study led to improved lung screening enrollment.
Although lung cancer screening can detect cancers early, its uptake remains low. Meanwhile, about 70% of women eligible for breast cancer screening report having a mammogram in the past two years, the researchers noted. Sandler and colleagues wanted to describe the impact of the CALM study, which aimed to find out whether screening mammography can be used as an opportunity to increase lung screening among women.
They included data from women who underwent screening mammography at two academic hospitals between 2019 and 2022. The researchers notified patients directly or through their healthcare providers of their lung screening eligibility.
Of the 32,165 women who participated in the study, 1,569 were eligible for lung cancer screening. Of these, 1,089 (69%) were not previously enrolled in lung screening.
The team reported that at one site, the total number of screenings significantly increased at one year compared to the number predicted from pre-intervention data (p = 0.011). It also found an increase in lung screenings, though nonsignificant, at the second site (p = 0.278).
The researchers suggested that the prolonged operational effects of the COVID-19 pandemic may have impacted the second site’s screening increase. These were not seen at the first site, they added.
Still the team suggested that such outreach strategies can be customized to different program structures and show success. Find out more in this session.
